Two UBC pharma stars recognized by the Order of Canada Zeposia: new oral treatment for relapsing-remitting multiple sclerosisThird oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada. Canadian pilot study of Vascepa shows promise against COVID-19 symptoms Five noteworthy medical advancements in 2020 for patient care 5 Tips: Risk reduction in peripheral arterial disease Peripheral artery disease is an under-diagnosed and undertreated diffuse systemic atherosclerotic disease. New product alert: Metamucil Premium Blend Dr. Ramneek Dosanjh to be president-elect for Doctors of BC Calgary MDs of all stripes volunteer for redeployment to ICUs Specialist who treated rare disease among homeless wants doctors to be aware of signs Epidural anesthesia reduces mortality in leg revascularization surgery First Previous 116 117 118 119 120 Next Last
